China's humanoid 'Super Bowl' signals 90% dominance

PLUS: Medtronic’s FDA win, new $62M fund


China's humanoid 'Super Bowl' signals 90% dominance

Welcome back to your Robot Briefing

Four Chinese humanoid startups performed coordinated routines on the country's most-watched television event, the CCTV Spring Festival Gala, as new data shows China now ships 90% of the world's humanoid robots.

With 13,000 units delivered in 2025 versus minimal Western output, and President Xi personally meeting robotics founders, the question for companies planning automation investments is no longer whether Chinese humanoids will dominate supply chains—but whether procurement teams can justify dependency on suppliers with direct government backing.

In today's Robot update:

China's humanoid 'Super Bowl' signals 90% market control
X-Humanoid releases open-source Tien Kung 3.0 platform
DIC Corporation launches $62M Physical AI fund
Medtronic's spine robot wins FDA clearance
News

China's humanoid 'Super Bowl' moment

China's humanoid 'Super Bowl' moment

Image Source: There's A Robot For That

Snapshot: China commanded the world's attention by showcasing humanoid robots on its most-watched TV event, the CCTV Spring Festival Gala, as new data reveals the country now controls 90% of global humanoid robot shipments.

Breakdown:

The gala drew 79% of China's live TV viewership last year and featured four rising humanoid startups (MagicLab, Unitree, Galbot, and Noetix) performing coordinated routines, making it comparable to a Super Bowl moment for Chinese industrial policy.
President Xi Jinping has met with five robotics startup founders in the past year, giving the sector unusual political visibility while companies like Galbot secure government-backed deployment contracts at CATL factories and border crossings.
China shipped roughly 13,000 humanoid robots in 2025 versus minimal U. S. output, with Morgan Stanley projecting Chinese sales will double to 28,000 units this year as Elon Musk acknowledges Chinese companies as Tesla's biggest Optimus competitors.

Takeaway: The coordinated display of political backing, manufacturing scale, and prime-time promotion signals China is moving humanoid robots from lab demonstrations to commercial deployment faster than Western competitors expected. Executives evaluating automation roadmaps now face a market where 90% of available humanoid robots come from Chinese suppliers with direct government support.

News

Tien Kung 3.0: A new open-source humanoid

Snapshot: China's X-Humanoid launched Embodied Tien Kung 3.0, positioning it as the first full-size humanoid with whole-body dynamic motion and tactile control—but the real story is the open architecture designed to lower barriers for integrators and speed commercial deployment.

Breakdown:

X-Humanoid has open-sourced key technologies including the robot body, motion control framework, AI models, training tools, and datasets to accelerate ecosystem development and reduce technical barriers for companies and researchers.
The platform delivers millimeter-level precision through high-torque joints and multi-degree-of-freedom coordination, enabling industrial-grade accuracy for manufacturing applications while maintaining stability on uneven terrain.
The Wise KaiWu AI platform enables fully autonomous operation with perception-decision-execution loops and supports multi-robot collaboration with cross-platform compatibility, marking a shift from single-unit demos to scalable commercial systems.

Takeaway: This represents China's bet on open ecosystems to dominate humanoid deployment—similar to how Android conquered mobile through accessibility rather than closed innovation. If open platforms gain traction faster than proprietary systems, the competitive landscape could shift quickly toward integrators who can customize rather than manufacturers who control everything.

News

Japan's DIC launches $62M 'Physical AI' fund

Snapshot: Tokyo-based DIC Corporation, a century-old chemicals and materials giant with €10B+ in annual revenue, has announced a $62 million investment portfolio targeting startups in sensors, wearables, robotics, and automation—signaling that traditional industrial players now view physical AI as core to their future.

Breakdown:

DIC isn't a typical VC but a manufacturing conglomerate with 170+ companies worldwide, making this move a signal that physical AI has crossed from tech speculation into industrial strategy.
The company is opening a dedicated subsidiary in Zurich this spring and partnering with Emerald Technology Ventures, a deep-tech VC with networks across Europe and North America, to source and support deals.
DIC plans to build a diversified startup portfolio over five years, focusing on technologies that combine sensors, robotics, and algorithms to interpret real-world environments—areas where their materials science expertise creates natural synergies.

Takeaway: When a $10B+ industrial manufacturer commits this level of capital and infrastructure to robotics startups, it validates that the technology has moved beyond pilot projects into strategic necessity. Companies evaluating automation investments should note this as a timing signal—traditional industry leaders are now competing for the same technologies that will define next-generation operations.

News

Medtronic wins FDA clearance for spine robot

Snapshot: Medtronic received FDA clearance for its Stealth AXiS robotics platform, marking a significant milestone as surgical robotics moves from specialized tools into mainstream hospital infrastructure through established medical device channels.

Breakdown:

The platform integrates planning, navigation, and execution into a single workflow, eliminating the need for hospitals to purchase and manage multiple separate systems for spine procedures.
Medtronic designed the system with modular scalability , allowing hospitals and ambulatory surgery centers to deploy only what they need initially and expand capabilities as clinical requirements grow.
The LiveAlign segmental tracking feature provides real-time visualization of anatomical movement during surgery, reducing the need for repeated imaging and minimizing manual workflow steps that slow procedures.

Takeaway: FDA clearance through a major medical device manufacturer like Medtronic signals that surgical robotics has crossed from experimental technology into standard hospital capital equipment. The modular pricing approach and integration into existing surgical workflows suggests adoption timelines for mid-sized healthcare systems are measured in quarters, not years.

Other Top Robot Stories

AGIBOT showcased its X2 humanoid at the 2026 World Artificial Intelligence Cannes Festival, engaging directly with French AI Minister Anne Le HĂ©nanff and Cannes Mayor David Lisnard to demonstrate China's embodied AI capabilities to European policymakers as the company expands beyond Asian markets.

Chinese published research in Science Advances on GrowHR, an inflatable humanoid robot that can shrink to 36% of its height, float on water, and navigate confined spaces—marking a departure from rigid metal designs as researchers explore soft robotics for search-and-rescue operations where adaptability matters more than load-bearing strength.

AGIBOT joined the UAE Lunar New Year Grand Parade in Dubai, deploying humanoid robots for public engagement as the Chinese manufacturer extends its Middle East presence beyond the manufacturing facilities and government contracts that have driven its global shipment leadership.

🤖 Your robotics thought for today:

13,000 humanoids shipped in 2025. Prime-time TV. Five founders in a room with the head of state.
That's what it looks like when an industry stops being a research project and becomes national infrastructure.
The question isn't who's ahead. It's: at what point does "we're still perfecting it" stop being a strategy?

What's your take?

Until tomorrow,
Uli

China's humanoid 'Super Bowl' signals 90% dominance

Great! Check your inbox and click the link to confirm.
Please enter a valid email address.